Incidence of venous thromboembolism following achilles tendon rupture. Data from the UK foot and ankle thrombo-embolism (UK-FATE) audit

IF 2.2 3区医学 Q3 CRITICAL CARE MEDICINE

Injury-International Journal of the Care of the Injured Pub Date : 2025-02-12 DOI:10.1016/j.injury.2025.112212

Matthew Solan , Samuel Briggs-Price , Linzy Houchen-Wolloff , Karan Malhotra , Lyndon Mason , Jitendra Mangwani , UK FATE Collaborative

{"title":"Incidence of venous thromboembolism following achilles tendon rupture. Data from the UK foot and ankle thrombo-embolism (UK-FATE) audit","authors":"Matthew Solan , Samuel Briggs-Price , Linzy Houchen-Wolloff , Karan Malhotra , Lyndon Mason , Jitendra Mangwani , UK FATE Collaborative","doi":"10.1016/j.injury.2025.112212","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Achilles tendon rupture (ATR) carries a high risk of venous thrombo-embolism (VTE) whether the injury is managed surgically or non-operatively. This study reports symptomatic VTE rate following ATR. The influence of patient demographics, treatment type and use of chemical thromboprophylaxis is examined.</div></div><div><h3>Materials and Methods</h3><div>Observational cohort study. The data is from a multi-centre, prospective, national audit of patients from 68 participating United Kingdom centres. Data was prospectively collected from hospital records. The study was conducted between June and November 2022, with a 3-month follow up.</div></div><div><h3>Results</h3><div>Of 11,363 participants in the National Audit, 9.5 % (<em>n</em> = 1084) had experienced an ATR. Management strategies included both non-surgical (74 %) and surgical (26 %). Following ATR, the VTE rate was 3.69 % (<em>n</em> = 40) compared to 0.57 % (<em>n</em> = 59) for other foot and ankle surgeries.</div><div>Participants who developed symptomatic VTE after ATR were older than those who did not (mean age 54 years (95 %CI 50.5 - 54.7) vs 48 years (95 %CI 47.3 - 49.1)). There was no significant difference in VTE events due to participant sex, ethnicity or number of comorbidities. Differences in treatment regimen, such as weight-bearing status and immobilisation strategy, showed no significant difference in symptomatic VTE events between groups.</div></div><div><h3>Conclusion</h3><div>After ATR, patients are 6.5-times more likely to experience symptomatic VTE than those recovering from surgery for other foot and ankle pathology. There was no significant difference in symptomatic VTE rate after ATR with specific chemical prophylaxis or early mobilisation strategies.</div></div>","PeriodicalId":54978,"journal":{"name":"Injury-International Journal of the Care of the Injured","volume":"56 3","pages":"Article 112212"},"PeriodicalIF":2.2000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Injury-International Journal of the Care of the Injured","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0020138325000725","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

Achilles tendon rupture (ATR) carries a high risk of venous thrombo-embolism (VTE) whether the injury is managed surgically or non-operatively. This study reports symptomatic VTE rate following ATR. The influence of patient demographics, treatment type and use of chemical thromboprophylaxis is examined.

Materials and Methods

Observational cohort study. The data is from a multi-centre, prospective, national audit of patients from 68 participating United Kingdom centres. Data was prospectively collected from hospital records. The study was conducted between June and November 2022, with a 3-month follow up.

Results

Of 11,363 participants in the National Audit, 9.5 % (n = 1084) had experienced an ATR. Management strategies included both non-surgical (74 %) and surgical (26 %). Following ATR, the VTE rate was 3.69 % (n = 40) compared to 0.57 % (n = 59) for other foot and ankle surgeries.

Participants who developed symptomatic VTE after ATR were older than those who did not (mean age 54 years (95 %CI 50.5 - 54.7) vs 48 years (95 %CI 47.3 - 49.1)). There was no significant difference in VTE events due to participant sex, ethnicity or number of comorbidities. Differences in treatment regimen, such as weight-bearing status and immobilisation strategy, showed no significant difference in symptomatic VTE events between groups.

Conclusion

After ATR, patients are 6.5-times more likely to experience symptomatic VTE than those recovering from surgery for other foot and ankle pathology. There was no significant difference in symptomatic VTE rate after ATR with specific chemical prophylaxis or early mobilisation strategies.

查看原文本刊更多论文

跟腱断裂后静脉血栓栓塞的发生率。数据来自英国足部和踝关节血栓栓塞（UK- fate）审计

无论是手术还是非手术治疗，跟腱断裂（ATR）都有发生静脉血栓栓塞（VTE）的高风险。本研究报告了ATR后的症状性静脉血栓栓塞率。患者人口统计学，治疗类型和使用化学血栓预防的影响进行了检查。材料与方法观察性队列研究。这些数据来自一项多中心、前瞻性的、对68个参与研究的英国中心的患者进行的国家审计。前瞻性地从医院记录中收集数据。该研究于2022年6月至11月进行，并进行了为期3个月的随访。结果在11363名国家审计参与者中，9.5% （n = 1084）经历过ATR。治疗策略包括非手术（74%）和手术（26%）。ATR术后VTE发生率为3.69% (n = 40)，而其他足踝手术的VTE发生率为0.57% （n = 59）。ATR后出现症状性静脉血栓栓塞的参与者比未出现症状性静脉血栓栓塞的参与者年龄大（平均年龄54岁（95% CI 50.5 - 54.7） vs 48岁（95% CI 47.3 - 49.1））。由于参与者的性别、种族或合并症的数量，静脉血栓栓塞事件没有显著差异。治疗方案的差异，如负重状态和固定策略，组间症状性静脉血栓栓塞事件无显著差异。结论ATR术后患者发生症状性静脉血栓栓塞的可能性是其他足部和踝关节病理术后恢复者的6.5倍。采用特殊的化学预防或早期动员策略的ATR后症状性静脉血栓栓塞率无显著差异。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Injury-International Journal of the Care of the Injured 医学-急救医学

CiteScore

4.00

自引率

8.00%

发文量

699

审稿时长

96 days

期刊介绍： Injury was founded in 1969 and is an international journal dealing with all aspects of trauma care and accident surgery. Our primary aim is to facilitate the exchange of ideas, techniques and information among all members of the trauma team.